The short version
13 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Clobetasol Propionate · CLOBETASOL PROPIONATE .4625 mg/mL · Solution · Topical · Macleods Pharmaceuticals Limited
NDC 33342-0321-39 · 1 BOTTLE in 1 CARTON / 25 mL in 1 BOTTLE · ANDA · View full market →
13 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | CLOBETASOL PROPIONATE .4625 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | CLOBETASOL PROPIONATE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | CLOBETASOL PROPIONATE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | CLOBETASOL PROPIONATE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | CLOBETASOL PROPIONATE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Encube Ethicals, Inc. | CLOBETASOL PROPIONATE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | CLOBETASOL PROPIONATE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | CLOBETASOL PROPIONATE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Lupin Pharmaceuticals,Inc. | CLOBETASOL PROPIONATE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | CLOBETASOL PROPIONATE .4625 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Micro Labs Limited | CLOBETASOL PROPIONATE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Novel Laboratories, Inc. | CLOBETASOL PROPIONATE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Quagen Pharmaceuticals LLC | CLOBETASOL PROPIONATE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | CLOBETASOL PROPIONATE .5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Clobetasol Propionate — NDC 33342-0321-39," retrieved September 3, 2026, https://drugdashboards.com/drug/33342032139.
Free to cite with attribution — see how the data is put together.